Views and Attitudes of Oncologists and Geriatricians on the Use of Chemotherapy and Hormone Therapy in Treating Older and/or Frail Women With Breast Cancer

City of Hope

Status: Completed

Conditions: Breast Cancer

Treatments: Other: survey administration

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT00478283

P30CA033572 (U.S. NIH Grant/Contract)

CHNMC-06187

CDR0000540280

Details and patient eligibility

About

RATIONALE: A patient's age, health, and ability to perform daily activities may affect which treatment options are offered by doctors to older and/or frail women with breast cancer.

PURPOSE: This clinical trial is studying the views and attitudes of oncologists and geriatricians on the use of chemotherapy and hormone therapy in treating older and/or frail women with breast cancer.

Full description

OBJECTIVES:

• Evaluate the attitudes and perspectives of 150 oncologists and 150 geriatricians or primary care providers regarding the adjuvant treatment of older women with breast cancer of varying ages, health, and functional status.
• Determine whether homogeneity exists in treatment recommendations.
• Determine the relative impact of chronological age, baseline health, and functional status on treatment recommendations.

OUTLINE: Participants complete a 25-minute online survey regarding their treatment recommendations for older women with breast cancer of varying ages, health, and functional status.

PROJECTED ACCRUAL: A total of 300 participants will be accrued for this study.

Enrollment: 300 estimated patients

Sex: All

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

DISEASE CHARACTERISTICS:

• Participants must meet 1 of the following criteria:

  • Oncologist:

    • Must have been in practice ≥ 2 years
    • Must have ≥ 25 postmenopausal breast cancer patients on adjuvant hormonal therapy
    • Cannot work for an advertising agency, market research company, manufacturer or distributor of pharmaceutical products, a pharmacy, drug store, or the FDA

  • Geriatrician:

    • Must have been in practice ≥ 2 years
    • Must be a general practitioner, family practitioner, internal medicine specialist, or geriatrician and received a certificate of added qualification in geriatric medicine and/or treating at least 5 postmenopausal patients who have a history of breast cancer or are currently undergoing treatment for breast cancer
    • Cannot work for an advertising agency, market research company, manufacturer or distributor of pharmaceutical products, a pharmacy, drug store, or the FDA

PATIENT CHARACTERISTICS:

• Not specified

PRIOR CONCURRENT THERAPY:

• Not specified